Chinese pharmaceutical company developing investigational respiratory medicines, including CXG87, an asthma therapy whose new drug application was accepted for regulatory review by China’s NMPA Center for Drug Evaluation
Chinese pharmaceutical company developing investigational respiratory medicines, including CXG87, an asthma therapy whose new drug application was accepted for regulatory review by China’s NMPA Center for Drug Evaluation. The search results do not establish that Shanghai Chenpon Pharmaceutical is the same company, so its products and platform are not attributed here.